Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia

L Hambach, M Eder, E Dammann, K Battmer… - Bone marrow …, 2001 - nature.com
We report a patient with Ph-positive CML who developed a Ph-negative AML in donor cells
14 months after BMT from an HLA-identical male unrelated donor. The Ph translocation …

Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme

F Khan, A Agarwal, S Agrawal - Bone marrow transplantation, 2004 - nature.com
The main goal of post-transplantation monitoring in hematopoietic stem cell transplantation
(HSCT) is to predict negative events, such as disease relapse, graft rejection and graft …

[HTML][HTML] Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain …

E Roux, C Helg, B Chapuis, M Jeannet, E Roosnek - Blood, 1992 - Elsevier
MATERIALS AND METHODS Patients. Twenty patients were transplanted with allogeneic
BM for the treatment of hematologic malignancies. Diagnosis, conditioning regimens …

Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia

MF Bertheas, M Lafage, P Levy, D Blaise, AM Stoppa… - 1991 - ashpublications.org
Serial cytogenetic studies were performed on 60 leukemic recipients of HLA-matched bone
marrow transplants (BMT) who were prepared by high doses of alkylating agents and …

Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing …

JF Beck, T Klingebiel, H Kreyenberg, A Schaudt… - Klinische …, 2002 - europepmc.org
Background Mortality in children with acute leukemias or MDS after allogeneic stem cell
transplantation (allo-SCT) is mostly determined by relapses. It was recently shown by us that …

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations

T Lion - Leukemia, 2001 - nature.com
The monitoring of chimerism has become a routine diagnostic instrument at centers
performing allogeneic stem cell or bone marrow transplantation. Despite the widespread …

Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation

KH Lee, JH Lee, SJ Choi, S Kim, M Seol… - Bone marrow …, 2003 - nature.com
Hematopoietic chimerism (HpC) was assayed monthly using a sensitive, polymerase chain
reaction (PCR)-based method in consecutive patients. Between January 1998 and April …

CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic …

B Mohr, R Koch, C Thiede, F Kroschinsky… - Bone marrow …, 2004 - nature.com
The aim of this study was to define factors that significantly influence the early kinetics of
donor chimerism after transplantation. In a retrospective study, the percentage of donor …

Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary …

T Lion - Leukemia, 2003 - nature.com
Reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR
amplification of microsatellite markers and capillary electrophoresis with fluorescence detection …

Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization

G Rondón, S Giralt, M Pereira, KV Besien… - Leukemia & …, 1997 - Taylor & Francis
Twelve patients (9 males and 3 females) with chronic myelogenous leukemia, underwent
CD8+ T cell depleted allogeneic bone marrow transplantation with a sex-mismatched donor …